Bioasis has brought together a team of exceptional leaders from the biopharmaceutical industry. Their experience in collaborative research, drug development, alliances and commercialization provides the vision and expertise to enable Bioasis to revolutionize the treatment of neurological diseases.
Deborah Rathjen, B.Sc. (Hons), Ph.D., MAICD, FTSE
Executive Chair, President and Chief Executive Officer
Chief Financial Officer
Caroline Clairmont, Ph.D.
Senior Vice President, Research & Development Operations
Mei Mei Tian, Ph.D.
Vice President, Head of External Research
Director, Investor Relations